A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma
暂无分享,去创建一个
Stefano Monti | Vinay K. Kartha | Xaralabos Varelas | S. Monti | X. Varelas | Liye Zhang | M. Bais | M. Kukuruzinska | S. Hiemer | Trevor Packer | M. Almershed | V. Noonan | Vinay K Kartha | Liye Zhang | Samantha E Hiemer | Trevor S Packer | Munirah Almershed | Vikki Noonan | Maria Kukuruzinska | Manish V Bais
[1] J. Ajani,et al. Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties. , 2014, Cancer research.
[2] O. Kirak,et al. Yap1 Acts Downstream of α-Catenin to Control Epidermal Proliferation , 2011, Cell.
[3] Jie Cheng,et al. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis. , 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[4] Y. Shyr,et al. Yes-Associated Protein Expression in Head and Neck Squamous Cell Carcinoma Nodal Metastasis , 2011, PloS one.
[5] Timothy R. Fallon,et al. Yap tunes airway epithelial size and architecture by regulating the identity, maintenance, and self-renewal of stem cells. , 2014, Developmental cell.
[6] J Silvio Gutkind,et al. Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer. , 2011, Cancer research.
[7] G. Feldmann,et al. Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals , 2007, Cell.
[8] Frederic A. Fellouse,et al. The Hippo pathway regulates Wnt/beta-catenin signaling. , 2010, Developmental cell.
[9] William C Hahn,et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. , 2003, RNA.
[10] K. Guan,et al. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). , 2010, Genes & development.
[11] F. Camargo,et al. The Hippo signaling pathway and stem cell biology. , 2012, Trends in cell biology.
[12] Xaralabos Varelas,et al. The Transcriptional Regulators TAZ and YAP Direct Transforming Growth Factor β-induced Tumorigenic Phenotypes in Breast Cancer Cells*♦ , 2014, The Journal of Biological Chemistry.
[13] Li Li,et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.
[14] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Machiels,et al. Targeted therapies for squamous cell carcinoma of the head and neck: current knowledge and future directions. , 2014, Cancer treatment reviews.
[16] M. Yaffe,et al. TAZ: a novel transcriptional co‐activator regulated by interactions with 14‐3‐3 and PDZ domain proteins , 2000, The EMBO journal.
[17] Helga Thorvaldsdóttir,et al. Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..
[18] Janet Rossant,et al. The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway. , 2010, Developmental cell.
[19] Q. Zeng,et al. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. , 2008, Cancer research.
[20] M. Yaffe,et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal , 2008, Nature Cell Biology.
[21] X. Varelas,et al. Head and neck cancer: from research to therapy and cure , 2014, Annals of the New York Academy of Sciences.
[22] S. Dupont,et al. The biology of YAP/TAZ: hippo signaling and beyond. , 2014, Physiological reviews.
[23] W. Hong,et al. TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation* , 2009, Journal of Biological Chemistry.
[24] Xudong Wang,et al. Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma. , 2011, Oral oncology.
[25] S. Bicciato,et al. The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells , 2011, Cell.
[26] X. Varelas,et al. The hippo pathway effector Yap controls patterning and differentiation of airway epithelial progenitors. , 2014, Developmental cell.
[27] S. Hilsenbeck,et al. Hippo pathway effector Yap is an ovarian cancer oncogene. , 2010, Cancer research.
[28] R. Myers,et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.
[29] M. Nita-Lazar,et al. Aberrant amplification of the crosstalk between canonical Wnt signaling and N-glycosylation gene DPAGT1 promotes oral cancer. , 2012, Oral oncology.
[30] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[31] R. Hynes,et al. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain , 2012, Proceedings of the National Academy of Sciences.
[32] X. Varelas,et al. Stem cell regulation by the Hippo pathway. , 2013, Biochimica et biophysica acta.
[33] R. Jaenisch,et al. YAP1 Increases Organ Size and Expands Undifferentiated Progenitor Cells , 2007, Current Biology.
[34] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[35] Giuseppe Basso,et al. YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response , 2014, Cell.
[36] J. Inazawa,et al. YAP is a candidate oncogene for esophageal squamous cell carcinoma. , 2011, Carcinogenesis.
[37] M. DePamphilis,et al. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. , 2001, Genes & development.
[38] E. Liu,et al. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway. , 2001, Cancer research.
[39] J. Downward,et al. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. , 2003, Molecular cell.
[40] Jiandie D. Lin,et al. TEAD mediates YAP-dependent gene induction and growth control. , 2008, Genes & development.
[41] David M. Thomas,et al. The Hippo pathway and human cancer , 2013, Nature Reviews Cancer.
[42] M. Nita-Lazar,et al. Overexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherin and cellular discohesion in oral cancer. , 2009, Cancer research.
[43] M. Brown,et al. YAP Dysregulation by Phosphorylation or ΔNp63-mediated Gene Repression Promotes Proliferation, Survival and Migration in Head and Neck Cancer Subsets , 2010, Oncogene.
[44] G. S. Chen,et al. [A study on survival rates of oral squamous cell carcinoma]. , 1996, Kaohsiung Journal of Medical Sciences.
[45] P. Söderkvist,et al. YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer. , 2014, Oral oncology.
[46] Xaralabos Varelas,et al. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease , 2014, Development.